FWM
ARNA

Filbrandt Wealth Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Filbrandt Wealth Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-30
Closed -$1K – 478
2020
Q1 		$1K Buy
+30
New +$1.38K ﹤0.01% 240

Other funds holding ARNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Filbrandt Wealth Management's ARNA Position: Q2 2020 in Review

Filbrandt Wealth Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2020, closing a stake of 30 shares — an estimated $1K sold.

Filbrandt Wealth Management first reported a position in ARNA in Q1 2020 and held it in 1 quarter. The position peaked at $1K in Q1 2020. 247 funds tracked by Wall St. Rank hold ARNA as of Q2 2020.

  • Filbrandt Wealth Management reported no remaining Arena Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Filbrandt Wealth Management sold 30 Arena Pharmaceuticals Inc shares in Q2 2020, an estimated $1K.
  • Filbrandt Wealth Management first reported a position in Arena Pharmaceuticals Inc in Q1 2020 and held it in 1 quarter.
  • Filbrandt Wealth Management's Arena Pharmaceuticals Inc position peaked at $1K in Q1 2020.
  • 247 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2020.

Based on Filbrandt Wealth Management's 13F filing for Q2 2020, filed 11 Aug 2020.